Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06382207 · ClinicalTrials.gov registry record · NA
Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs
A NA study of Tachyarrhythmia, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06382207: Recruiting NA study of Tachyarrhythmia, sponsored by Virginia Commonwealth University.
NCT06382207 is a NA study of Tachyarrhythmia that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06382207, a NA study of Tachyarrhythmia, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.
Primary Outcome
Number and proportion of good-quality ECG recordings taken by physicians, for DUO and for CORE 500. A "good-quality" ECG recording is defined as one where the tracing is clear enough and with sufficient amplitude to define the p-wave, QRS complex, and t-wave, beyond a reasonable doubt, to allow determination of the patient's cardiac rhythm, by two independent pediatric electrophysiologists and a pediatric cardiologist.
Conditions Studied
Interventions
- DEVICE Eko Duo electronic stethoscope
- DEVICE CORE 500 electronic stethoscope
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-17 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT06382207 shows while recruiting
NCT06382207 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Tachyarrhythmia appearing as the primary indexed condition, and to 2 interventions - of which Eko Duo electronic stethoscope is the first listed.
NCT06382207 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06382207 about?
NCT06382207 is a clinical study titled "Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs". When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their c...
What is the current status of trial NCT06382207?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-01-17. Estimated completion is 2026-07.
What conditions does trial NCT06382207 study?
This clinical trial studies the following conditions: Tachyarrhythmia.
What interventions are being tested in trial NCT06382207?
The interventions under investigation include: Eko Duo electronic stethoscope (DEVICE), CORE 500 electronic stethoscope (DEVICE).
Who is sponsoring clinical trial NCT06382207?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06382207 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachyarrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06382207's enrollment target sits among peer trials
100 841st of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI